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Abstract: Dementia is a risk factor for unsafe driving. Therefore, an
assessment strategy has recently been developed for the prediction
of ﬁtness to drive in patients with the Alzheimer disease (AD). The
aim of this study was to investigate whether this strategy is also
predictive of ﬁtness to drive in patients with non-AD dementia, that
is, vascular dementia, frontotemporal dementia, and dementia with
Lewy bodies. Predictors were derived from 3 types of assessment:
clinical interviews, neuropsychological tests, and driving simulator
rides. The criterion was the pass-fail outcome of an ofﬁcial on-road
driving assessment. About half of the patients with non-AD
dementia (n= 34) failed the on-road driving assessment. Neuro-
psychological assessment [area under the curve (AUC)= 0.786] was
signiﬁcantly predictive of ﬁtness to drive in patients with non-AD
dementia, however, clinical interviews (AUC= 0.559) and driving
simulator rides (AUC= 0.404) were not. The ﬁtness-to-drive
assessment strategy with the 3 types of assessment combined
(AUC= 0.635) was not found to signiﬁcantly predict ﬁtness to drive
in non-AD dementia. Different types of dementia require different
measures and assessment strategies.
Key Words: vascular dementia, frontotemporal dementia, dementia
with Lewy bodies, car driving, ﬁtness-to-drive assessment
(Alzheimer Dis Assoc Disord 2017;00:000–000)
The most common types of dementia are Alzheimerdisease (AD), vascular dementia (VaD), frontotemporal
dementia (FTD), and dementia with Lewy bodies (DLB).1
In early stages, different patterns of cognitive dysfunctions
may be present in patients with different types of dementia.
Initial impairments of AD usually lie in the cognitive
domain of memory, whereas, VaD often starts with cogni-
tive slowing, FTD with behavioral or language impairments
and DLB with visuospatial impairments. These different
impairments may have different effects on activities of daily
living such as driving.2,3
Many patients with different types of dementia continue
driving,4 but dementia is a risk factor for trafﬁc accidents.
There is consensus that patients with moderate to severe
dementia should not drive anymore.5 However, in the early
stages of dementia, some patients still drive safely, whereas
others do not.5 In order to advise patients with mild dementia
about driving, patients should be assessed on ﬁtness to
drive.2,6,7 On-road driving assessments are the “gold stand-
ard” because of a high face validity, but it is not feasible
to assess all drivers with dementia on the road. A reliable
and validated ﬁtness-to-drive assessment strategy for clinical
application would therefore be useful.8 However, it seems
crucial to validate ﬁtness-to-drive assessment strategies for
patients with different types of dementia separately, because
they may vary in symptoms and in the effects of symptoms on
driving behavior.2,9,10
Studies on driving with non-AD dementia are scarce.
There is only 1 study on driving with VaD,6 which showed
that patients with VaD made more driving errors on the
road than healthy participants.6 Patients with VaD might
not operate a car quickly enough and may not perceive
other road users or signs in time as a consequence of cog-
nitive slowing.2 Nonetheless, some patients with VaD have
mild symptoms for a long time and these patients may be
safe drivers for several years after diagnosis.
Driving with FTD was investigated using interviews and
driving simulators, but no on-road driving assessments were
reported yet.9,11–13 Antisocial behavior, agitation, impulsivity,
and distraction due to FTD may lead to speeding, ignoring
road signs, running red lights, and not recognizing pedestrians
at intersections, all having the clear potential to cause
accidents.9,11–13 Moreover, impairment of judgment may
cause difﬁculty estimating distances between vehicles,9 and
result in a lack of understanding that particular driving
behavior is inappropriate and risky.11 On the basis of the
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moderately progressive course and early behavioral symp-
toms, it has been suggested that patients with FTD should
cease driving soon after diagnosis.9,11,14
There is only 1 study on driving with DLB.15 In this
driving simulator study, patients with DLB were regularly
speeding, swerving, running red lights, and causing
accidents.15 DLB has a slowly progressive course, but the
initial symptoms, that is, visual hallucinations, visuospatial
impairments, ﬂuctuations in attention, and parkinsonism,
may already impede safe driving at the time of diagnosis.14
To address the need for validated ﬁtness-to-drive assess-
ment strategies, an assessment strategy was developed recently
for patients with AD.7 The assessment strategy consisted
of clinical interviews, a neuropsychological assessment, and
driving simulator rides, because these 3 types of assessments
were shown to provide nonredundant information for the
prediction of ﬁtness to drive in patients with AD. The aim of
the present study is to investigate whether the suggested
assessment strategy is also predictive for ﬁtness to drive in
patients with VaD, FTD, and DLB. We hypothesize that the
proposed strategy will aid the prediction of ﬁtness to drive,
because cognitive and functional aspects important for driving
are assessed. However, the differences in clinical syndromes
of VaD, FTD, and DLB may result in a considerable drop in
predictive accuracy compared with the original study on
patients with AD. The measures of the 3 types of assessments
may differ in how disease-speciﬁc they are in predicting ﬁtness




Participants were recruited and assessed according to
the study protocol described by Piersma et al.7 The study
was approved by the Medical Ethical Committee at the
University Medical Center Groningen, the Netherlands.
Inclusion criteria for patients were an age above 30, a valid
driving license, a wish to continue driving, and a diagnosis
of dementia in very mild to mild stages (clinical dementia
rating <2). Exclusion criteria were the diagnosis of neuro-
logical or psychiatric conditions unrelated to dementia that
may inﬂuence driving performance and usage of medi-
cations legally incompatible with driving (ICADTS category
III drugs). In addition, patients were screened on visual
functions according to legal limits for driving, that is, a
minimum visual acuity of 0.5 and a minimum horizontal
ﬁeld of view of 120 degrees.
Referring physicians established the diagnosis of VaD
with the NINDS-AIREN criteria,16 the diagnosis of
FTD and its variants by the criteria of the International
bvFTD Criteria Consortium17 and the International PPA
Consortium,18 and the diagnosis of DLB using the criteria
of the DLB consortium.19 Two patients with VaD had to be
excluded because they did not fulﬁll the visual requirement
of a minimum horizontal visual ﬁeld of 120 degrees,
resulting in 14 patients with VaD who completed the study.
Moreover, 2 patients with FTD had to be excluded because
their visual acuity was below the requirement of 0.5. Two
additional patients with FTD were excluded because they
did not perform the on-road assessment. Hence, 12 patients
with FTD completed the study. The behavioral variant of
FTD was diagnosed in 7 cases, the semantic variant in 2
cases and primary progressive aphasia in 1 case. One case
was diagnosed with both the behavioral and semantic var-
iant of FTD. In 1 case, the diagnosis of FTD was not
speciﬁed as a particular variant. Finally, 8 patients with
DLB participated in this study. Table 1 shows character-
istics of the 3 patient groups.
Measures
The following description of methods entails only the
measures used in the prediction equations as derived from the
original study.7 Measures of clinical interviews included 2
subscores of the clinical dementia rating, that is, orientation
and judgment as well as problem solving,20 the patients’
judgments of their own driving safety, and recent driving
experience. The neuropsychological assessment comprised the
Mini-Mental State Examination (MMSE),21,22 the reaction
time S2,23 the hazard perception test,24 and a trafﬁc theory
TABLE 1. Characteristics of Patients With VaD, FTD, and DLB
Group
Characteristics VaD (N= 14) FTD (N= 12) DLB (N= 8)
Age [mean (SD)] (y) 75.0 (5.3) 67.3 (10.3) 71.7 (10.3)
Male sex [n (%)] 12 (85.7) 9 (75.0) 7 (87.5)
Education [mean of 7 stages (SD)] 4.6 (1.1) 5.2 (0.8) 5.3 (1.8)
CDR-score [n (%)]
0 0 (0.0) 1 (8.3) 3 (37.5)
0.5 11 (78.6) 9 (75.0) 4 (50.0)
1 3 (21.4) 2 (16.7) 1 (12.5)
MMSE score [mean (SD)] 22.3 (2.1) 25.2 (3.1) 26.3 (2.8)
Medication affecting the CNS [n (%)] 5 (35.7) 2 (16.7) 2 (25.0)
Driving experience [mean (SD)] (y) 54.2 (7.0) 46.2 (7.2)* 48.8 (9.2)
Driving experience [mean (SD)] (km) 2,454,000 (3,790,000) 1,500,000 (2,641,000)† 1,208,000 (716,000)
Car accident in past year [n (%)] 2 (14.3) 1 (8.3) 1 (12.5)
Trafﬁc ticket in past year [n (%)] 1 (7.1) 4 (33.0) 2 (25.0)
Education, Verhage scale for the Dutch educational level ranging from 1 (primary school not ﬁnished) to 7 (university level).
Medications include antidepressants, cholinergic medications, dopaminergic medication, GABAergic medication, and a natural sedative.
*For 11 of 12 patients, as 1 patient did not report the information.
†For 10 of 12 patients, as 2 patients did not report the information.
CDR-score indicates clinical dementia rating total score; CNS, central nervous system; DLB, dementia with Lewy bodies; FTD, frontotemporal dementia;
MMSE score, Mini-Mental State Examination Sum score (range, 0 to 30); VaD, vascular dementia.
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test (see Piersma et al7 for details). Fixed-based Jentig50
driving simulators of ST Software were used. Driving simu-
lator measures included the minimum speed when approach-
ing an intersection with trafﬁc lights, the number of collisions
in a ride with intersections and 2 measures concerning a
merging maneuver, that is, the deceleration of the rear car
after merging and the time headway directly after merging
(see Piersma et al7 for details).
The on-road driving assessments were carried out by
approved experts on practical ﬁtness to drive of the Dutch
driving test organization (CBR). Experts were blind to the
participants’ diagnoses and test results. They rated driving
behavior of patients on the Test Ride Investigating Practical
ﬁtness to drive forms.25,26 Finally, a pass, doubtful or fail out-
come was given by the expert. This outcome was recoded into a
dichotomous item which indicates whether or not a participant
is ﬁt to drive, that is, pass outcomes indicated that participants
could retain their driving license, whereas doubtful or fail out-
comes indicated that participants would have lost their driving
license if this was an ofﬁcial relicensing assessment.
Statistical Analyses
Missing Data
The trafﬁc theory test measure of 1 patient with VaD was
missing. Because of simulator sickness, 7 (50.0%) patients with
VaD, 3 (25.0%) patients with FTD, and 2 (25.0%) patients
with DLB were excluded entirely from analyses that involved
driving simulator rides. Because of technical problems, driving
simulator measures of 1 patient with VaD and of 1 patient
with FTD were missing. In addition, 1 driving simulator
measure, that is, the deceleration of the rear car after merging,
was missing of 1 patient with VaD and 1 patient with DLB,
because these participants merged onto the motorway after all
cars had passed. As these 2 patients did complete the driving
simulator rides, it was decided to impute the 2 missing values
using an imputation model (including all complete variables of
the speciﬁc patient group) that was estimated by maximum
likelihood, providing a singly imputed data set.
Evaluation of the Prediction Model for Fitness to Drive
The goal of the analysis was to evaluate whether ﬁtness
to drive of patients with non-AD dementia can be predicted
with a prediction model that has been developed using data
of patients with AD.7 The previously proposed prediction
equations were applied using data of 34 patients with non-
AD dementia: 14 VaD, 12 FTD, and 8 DLB. Receiver
operating characteristic (ROC) analyses were used to eval-
uate the predictive accuracy of the model. The area under
the curve (AUC) was used as a classiﬁcation measure with
larger areas indicating better predictive accuracy. The 3
groups of predictor variables, that is, clinical interviews,
neuropsychological assessment and driving simulator rides,
and the complete approach (ie, variables from all groups of
predictors) were evaluated in separate ROC analyses to
explore the accuracy of each set of variables in predicting
ﬁtness to drive for non-AD dementia.
RESULTS
Four of 14 patients with VaD, 5 of 12 patients with
FTD, and 5 of 8 patients with DLB passed the on-road
driving assessment. Overall, 14 (41.2%) patients passed and
20 (58.8%) patients failed the on-road driving assessment.
Results of patients who passed and failed the on-road
assessment are presented in Table 2.
Prediction equations derived from the previous study
on patients with AD were applied.7 ROC analysis showed
that the clinical interviews (n= 34) were not predictive of
ﬁtness to drive in patients with non-AD dementia with a
nonsigniﬁcant AUC close to chance level (AUC= 0.559,
SE= 0.104, P= 0.564). In contrast, ROC analysis revealed
that neuropsychological assessment (n= 33) was predictive
of ﬁtness to drive in this patient group with a signiﬁcant
AUC of 0.786, SE= 0.081, P= 0.006. Similar to clinical
interviews, driving simulator rides (n= 20) were not found to
aid the prediction of ﬁtness to drive in patients with non-AD
dementia (AUC= 0.417, SE= 0.130, P= 0.537). The com-
plete approach with the 3 types of assessments combined
(n= 20) was not useful for the prediction of ﬁtness to drive in
TABLE 2. Comparison of Patients With Non-AD Dementia Who
Passed and Who Failed the On-road Driving Assessment on
Predictor Variables*
Clinical Interviews Pass (n= 14) Fail (n= 20) ESa
CDR orientation 0.3 (0.3) 0.6 (0.5) 0.77
CDR judgment and
problem solving
0.6 (0.4) 0.7 (0.4) 0.22
Judgment driving
safetyb
1.2 (0.4) 1.2 (0.4) 0.03
Recent driving
experiencec
2.6 (0.8) 2.8 (1.6) 0.14
Neuropsychological
assessment
Pass (n= 14) Fail (n= 19)
MMSE score 24.9 (2.7) 23.6 (3.3) 0.46
RT S2 RT (ms) 281.3 (47.5) 426.9 (258.5) 0.75
Hazard perception
(correct trials)
15.8 (2.7) 12.5 (4.2) 0.93
Trafﬁc theory
(response time in s)
7.4 (0.7) 8.0 (1.3) 0.52
Driving simulator
rides




4.1 (10.8) 10.2 (20.8) 0.37




−0.6 (1.1) −1.3 (2.1) 0.42
Time headway after
merging (s)
1.4 (0.6) 1.0 (0.5) 0.78
aES is indicated by Cohen’s d.
bJudgment about driving safety whether participant is (1) still driving as
safely as when the participant was middle aged, (2) is driving less safely
compared with when the participant was middle aged, or (3) drives unsafely.
cKilometers driven in the previous 12 months: (1) <1.000 km, (2) 1.000 to
5.000 km, (3) 5.000 to 10.000 km, (4) 10.000 to 20.000 km, (5) 20.000 to
30.000 km, (6) 30.000 to 50.000, (7) > 50.000 km.
dIntersection with need to give right of way, the trafﬁc lights at this
intersection turn yellow and subsequently red.
*Prediction equations: clinical interviews=CDR orientation×0.675
+CDR judgment and problem solving×1.036+judgment driving safety×1.250
+recent driving experience×−0.576. Neuropsychological assessment=
MMSE×0.129+RT S2 RT×−0.003+correct trials of hazard percep-
tion×0.206+response time of trafﬁc theory×−0.310. Driving simulator
rides=minimum speed intersection 2×0.021+Number of collisions×0.738
+deceleration rear car×−0.367+time headway×0.732. Complete approach=
clinical interviews×0.328+neuropsychological assessment×−0.620+driving
simulator rides×0.483.
AD indicates Alzheimer’s disease; CDR, clinical dementia rating (range,
0 to 3); ES, effect size; Hazard perception, hazard perception test (range, 0 to
25); MMSE score, Mini-Mental State Examination Sum score (range, 0 to
30); RT S2 RT, reaction time test S2 reaction time.
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this sample of patients with non-AD dementia (AUC=
0.635, SE= 0.129, P= 0.316).
The patient groups were too small to evaluate the
prediction model for the 3 types of dementia separately,
however, to get an idea whether the results from the 3 dif-
ferent types of non-AD dementia diverge, their mean scores
on the predictor variables were explored (Table 3). Patients
with VaD had poorer mean scores on the predictor variables
of clinical interviews and neuropsychological assessment
than patients with FTD and patients with DLB, which was
particularly evident for the scores on the MMSE and the
hazard perception test. In general, patients with DLB had
“safer” mean scores on the predictor variables than the
other 2 patient groups, for example an adequate reaction
time S2 score. Notably, patients with FTD judged their own
driving safety as safe, but approached an intersection with
trafﬁc lights with a high speed compared with the other 2
patient groups. Nonparametric comparisons using Kruskal-
Wallis tests showed statistically signiﬁcant differences
between the patient groups in MMSE score, χ2(2)= 10.228,
P= 0.006; hazard perception (correct trials), χ2(2)= 10.198,
P= 0.006; trafﬁc theory (response time), χ2(2)= 7.852,
P=0.020; and the number of collisions in the driving simulator,
χ2(2)=6.358, P=0.042. Mann-Whitney post hoc tests indi-
cated worse performance of patients with VaD compared with
the other 2 groups of patients in the majority of comparisons
(Table 3). In conclusion, the 3 patient groups seemed to differ
in their scores on the predictor variables.
DISCUSSION
About half of the patients failed the on-road driving
assessment suggesting that VaD, FTD, and DLB are risk
factors for unsafe driving. This is in line with previous
studies showing that patients with VaD make more driving
errors on the road and that patients with FTD and DLB
make more driving errors in driving simulation, in com-
parison with healthy drivers.6,12,15 Nevertheless, a consid-
erable proportion of patients of each type of dementia
passed the on-road driving assessment. Likewise, Fitten
et al6 showed a large variation in on-road driving per-
formance among patients with VaD indicating that some
patients with VaD are ﬁt to drive, whereas, others are unﬁt
to drive. Although research including on-road driving of
patients with FTD and DLB was lacking, it has been argued
that patients with FTD and DLB should cease driving very
soon after the diagnosis is established.9,11,14 In a study by
Seiler et al,4 only 9 of 16 patients with FTD had ceased
driving (a rate comparable with patients with AD and
VaD), whereas as many as 10 of 11 patients with DLB had
ceased driving. The current study suggests that not all
patients with FTD and DLB are unﬁt to drive. Con-
sequently, all patients with dementia who wish to continue
driving should be assessed on ﬁtness to drive.
In this study, it was found that the prediction model for
ﬁtness to drive in patients with AD was not predictive for
ﬁtness to drive in patients with non-AD dementia (AUC=
0.635). Although the applied neuropsychological assessment
battery was of signiﬁcant value for the prediction of ﬁtness to
drive in patients with non-AD dementia (AUC= 0.786), the
selections of predictor variables from clinical interviews
(AUC= 0.559) and driving simulator rides (AUC= 0.417)
were not. Clinical interviews may be of limited utility for the
prediction of ﬁtness to drive in patients with dementia, because
it requires insight of patients into their own abilities, and
careful attention of informants to the patients’ behavior. In
this study, patients with FTD estimated their driving safety as
not being declined which is in accordance with a previous
study stating that patients with FTD may not realize that their
driving behavior is risky.11 It can be concluded that the pri-
mary use of clinical interviews is to discuss the impact of
dementia on driving and to score the severity of dementia.
TABLE 3. Predictor Variables of Patients With VaD, FTD, and DLB
Predictor Variables Group Mean (SD) KW Test Mann-Whitney U Tests
Clinical Interviews VaD (n= 14) FTD (n= 12) DLB (n= 8) P VaD-FTD VaD-DLB FTD-DLB
CDR orientation 0.6 (0.5) 0.4 (0.4) 0.3 (0.3) 0.123
CDR judgment and problem solving 0.7 (0.3) 0.6 (0.4) 0.5 (0.4) 0.294
Judgment driving safetya 1.2 (0.4) 1.1 (0.3) 1.4 (0.5) 0.227
Recent driving experienceb 2.3 (1.1) 2.8 (1.6) 3.1 (1.0) 0.243
Neuropsychological assessment VaD (n= 13) FTD (n= 12) DLB (n= 8)
MMSE score 21.9 (1.7) 25.2 (3.1) 26.3 (2.8) 0.006* 0.016* 0.005* 0.269
Reaction time S2 (ms) 406 (313) 366 (116) 297 (52) 0.525
Hazard perception (correct trials) 11.1 (3.6) 15.3 (3.4) 16.5 (2.1) 0.006* 0.014* 0.004* 0.449
Trafﬁc theory (response time in s) 8.3 (1.0) 7.3 (0.9) 7.4 (1.1) 0.020* 0.008* 0.051 1.000
Driving simulator rides VaD (n= 6) FTD (n= 8) DLB (n= 6)
Minimum speed at intersection (km/h)c 2.8 (6.6) 13.4 (24.8) 5.1 (12.6) 0.359
No. collisions 1.3 (0.8) 0.4 (0.7) 0.3 (0.8) 0.042* 0.027* 0.055 0.866
Deceleration rear car after merging (km/h) −1.2 (1.4) −1.5 (2.4) 0.0 (0.0) 0.197
Time headway after merging (s) 1.1 (0.6) 1.4 (0.6) 0.8 (0.4) 0.283
aJudgment about driving safety whether patient is (1) still driving as safely as when the patient was middle aged, (2) is driving less safely compared with when
the patient was middle aged, or (3) drives unsafely.
bKilometers driven in the previous 12 months: (1) <1.000 km, (2) 1.000 to 5.000 km, (3) 5.000 to 10.000 km, (4) 10.000 to 20.000 km, (5) 20.000 to 30.000 km,
(6) 30.000 to 50.000, (7) > 50.000 km.
cIntersection with need to give right of way, the trafﬁc lights at this intersection turn yellow and subsequently red.
*Statistical signiﬁcance (P< 0.05).
CDR indicates clinical dementia rating (range, 0 to 3); DLB, dementia with Lewy bodies; FTD, frontotemporal dementia; Hazard perception, hazard
perception test (range, 0 to 25); KW test, Kruskal-Wallis test; MMSE score, Mini-Mental State Examination Sum score (range, 0 to 30); VaD, vascular dementia.
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Furthermore, the selected measures from the driving
simulator rides may not serve the prediction of ﬁtness to
drive in patients with non-AD dementia, because these
measures do not represent all critical trafﬁc situations, and
patients with different types of dementia may have difﬁ-
culties in different trafﬁc situations. This would suggest that
other driving simulator measures might be better predictors
in patients with non-AD dementia. To start with, different
measures from the current driving simulator rides could be
investigated, for example, measures reﬂecting lane control.
Another issue with driving simulation is that some measures
are difﬁcult to interpret in terms of “safe” or “unsafe”
driving, as both a high and a low value may indicate poor
driving performance. For example, 1 patient group might be
too slow, whereas another patient group might be too fast in
similar situations of simulated driving. A solution might be
using measures differently for different patient groups, for
example, driving slowly might predict unsafe driving in
patients with VaD, whereas speeding could be a predictor
for unsafe driving in patients with FTD and DLB. Cur-
rently, driving simulator rides provide a safe environment
for subjective clinical evaluations of ﬁtness to drive, but
objective evidence-based measures with cutoffs still have to
be deﬁned for the prediction of ﬁtness to drive in non-AD
dementia.
The applied neuropsychological assessment was useful
for ﬁtness-to-drive evaluations in patients with non-AD
dementia, especially speciﬁc trafﬁc tests may have the
potential to predict ﬁtness to drive in multiple types of
dementia. This ﬁts with the promising results with Drive-
Safe/DriveAware in groups of patients with cognitive
impairments related to a variety of diagnoses.27,28 When
developing new assessment strategies, it should also be
considered which symptoms and impairments are likely to
result in unsafe driving per etiology and how these can be
assessed. For example, cognitive slowing in VaD and
visuospatial functions in DLB could be evaluated in a
neuropsychological assessment.29 Patients with FTD show
impairments of behavior (do) rather than of maximal per-
formance (can do), which is difﬁcult to measure with neu-
ropsychological tests. As it is common for patients with
FTD not to realize that their driving behavior is risky,
inquiries with informants could be included when inves-
tigating ﬁtness to drive in FTD. In brief, different algo-
rithms using different measures may be needed to predict
ﬁtness to drive in patients with different types of dementia.
In future studies on ﬁtness to drive in patients with
non-AD dementia, dichotomized outcome scores might not
always be feasible, therefore trichotomization may need to
be considered.30 This means that outcome scores will be
divided into 3 groups: safe, unsafe, and indeterminate. The
latter group should be referred to additional ﬁtness-to-drive
assessments. Such an approach could improve the classi-
ﬁcation of driving safety.
This is the ﬁrst study in which the prediction of ﬁtness
to drive in patients with 3 different types of non-AD
dementia was investigated. Strengths of the study are that all
patients were assessed according to the same protocol and
that on-road driving evaluations were performed. In many
studies on ﬁtness to drive, patients with AD and other types
of dementia were pooled into 1 group. In this study, it was
found that the prediction equation with measures from
clinical interviews, neuropsychological assessment, and
driving simulator rides that predicted ﬁtness to drive in
patients with AD did not apply to patients with non-AD
dementia. These ﬁndings may imply that it is not possible to
predict ﬁtness to drive for all patients with dementia with 1
assessment strategy. Moreover, patients with different types
of non-AD dementia also seem to differ in ﬁtness-to-drive
assessment results based on the exploration of their mean
scores, which indicates that ﬁtness-to-drive assessment
strategies require validation for each type of dementia sep-
arately. It is important to note that the differences in mean
scores between the patient groups are likely to be affected by
the severity of cognitive impairment (ie, the severity of
cognitive impairment may have been worse in patients with
VaD than in patients with FTD and DLB in this sample), in
addition to the different types of dementia. The hetero-
geneity of the samples of patients with dementia may par-
tially explain why predictive accuracies of ﬁtness-to-drive
assessment strategies were often low in previous studies.31
In the current study, 3 types of dementia were pooled
into 1 non-AD dementia group, because of small sample sizes.
As a consequence, the results do not reveal whether the pro-
posed assessment strategy was, for example, predictive for 1 of
the 3 types of dementia included. To investigate this, the
number of correct classiﬁcations for each type of dementia
was counted after application of cutoff −0.6 as suggested in
the original study.7 For patients with VaD, the cutoff was too
strict, because all 6 patients with VaD were classiﬁed as fail,
whereas 2 of them passed the on-road assessment. For
patients with DLB, the cutoff was too lenient since all 6
patients with DLB were classiﬁed as pass, whereas 3 of them
failed the on-road assessment. In the FTD group, the classi-
ﬁcation accuracy was better, nonetheless, 2 of 8 patients were
incorrectly classiﬁed as pass. These results conﬁrm that the
proposed strategy cannot predict ﬁtness to drive in each group
of patients with non-AD dementia.
In conclusion, the results of this study show that a valid
assessment strategy for the prediction of ﬁtness to drive in
patients with AD7,32 is not useful for the prediction of ﬁtness
to drive in patients with non-AD dementia. This is in line
with previously stated notions that each type of dementia
has its own typical symptoms, resulting in different
impairments and variations in driving behavior.2,9 The
implication of the ﬁndings is that assessment strategies for
the prediction of ﬁtness to drive should be developed spe-
ciﬁcally tailored to VaD, FTD, and DLB.
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